The prevalence of PALB2 germline mutations in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives (original) (raw)

Abstract

PALB2 has been recently identified as breast cancer susceptibility gene in western populations. To investigate the contribution of PALB2 mutations to Chinese non-BRCA1/BRCA2 hereditary breast cancer, we screened all coding exons and intron-exon boundaries of PALB2 in 360 Chinese women with early-onset breast cancer or affected relatives from five breast disease clinical centers in China by utilizing PCR-DHPLC and DNA sequencing analysis. Some genetic variants identified in the cases were then studied in 864 normal controls with no personal or family history of breast cancer. Two protein-truncating PALB2 mutations, 751C>T and 1050_1051delAAinsTCT, were identified in three separate families, and 751C>T was a recurrent mutation. Neither of them, however, were present in the controls (P = 0.025). All the truncating mutations occured in exon 4 of PALB2, and there were still three unclassified variants were detected in the same fragment. We found that exon 4 accounted for 44.1% (15/34) of the person-times carrying with any variant in our study. PALB2 mutations were responsible for approximately 1% of Chinese women with early-onset breast cancer and affected relatives. Our results suggested that a detection of exon 4 before the assay of the whole PALB2 gene might be a cost-effective approach to the screening of Chinese population.

Access this article

Log in via an institution

Subscribe and save

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Li WF, Hu Z, Rao NY et al. (2007) The prevalence of BRCA1 and BRCA2 germline mutations in high-risk breast cancer patients of Chinese Han nationality: two recurrent mutations were identified. Breast Cancer Res Treat doi:10.1007/s10549-007-9708-3 (in press)
  2. Xia B, Sheng Q, Nakanishi K, Ohashi A et al (2007) Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2. Mol Cell 22:719–729
    Article CAS Google Scholar
  3. Simpson S (2007) PALB2-new breast-cancer susceptibility gene. Lancet Oncol 8(2):105
    Article PubMed Google Scholar
  4. Xia B, Dorsman JC, Ameziane N et al (2007) Fanconi anemia is associated with a defect in the BRCA2 partner PALB2. Nat Genet 39:159–161
    Article PubMed CAS Google Scholar
  5. Reid S, Schindler D, Hanenberg H et al (2007) Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer. Nat Genet 39:162–164
    Article PubMed CAS Google Scholar
  6. Howlett NG (2007) Fanconi anemia: Fanconi anemia, breast and embryonal cancer risk revisited. Eur J Hum Genet 15:715–7
    Article PubMed Google Scholar
  7. Walsh T, King MC (2007) Ten genes for inherited breast cancer. Cancer Cell 11:103–105
    Article PubMed CAS Google Scholar
  8. Offit K (2006) BRCA mutation frequency and penetrance: new data, old debate. J Natl Cancer Inst 98:1675–1677
    Article PubMed Google Scholar
  9. Rahman N, Seal S, Thompson D et al (2007) PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat Genet 39:165–167
    Article PubMed CAS Google Scholar
  10. García MJ, Fernández V, Osorio A et al. (2008) Analysis of FANCB and FANCN/PALB2 Fanconi Anemia genes in BRCA1/2-negative Spanish breast cancer families. Breast Cancer Res Treat doi:10.1007/s10549–008-9945-0 (in press)
  11. Foulkes WD, Ghadirian P, Akbari MR et al (2007) Identification of a novel truncating PALB2 mutation and analysis of its contribution to early-onset breast cancer in French–Canadian women. Breast Cancer Res 9:R83
    Article PubMed CAS Google Scholar
  12. Erkko H, Xia B, Nikkilä J et al (2007) A recurrent mutation in PALB2 in Finnish cancer families. Nature 446:316–319
    Article PubMed CAS Google Scholar
  13. Tischkowitz M, Xia B, Sabbaghian N et al (2007) Analysis of PALB2/FANCN-associated breast cancer families. Proc Natl Acad Sci USA 104:6788–6793
    Article PubMed CAS Google Scholar
  14. Offit K (2000) Are BRCA1- and BRCA2-associated breast cancers different? J Clin Oncol 18:104–106
    Google Scholar
  15. Phillips KA (2000) Immunophenotypic and pathologic differences between BRCA1 and BRCA2 hereditary breast cancers. J Clin Oncol 18:107–112
    Google Scholar
  16. Armes JE, Venter DJ (2002) The pathology of inherited breast cancer. Pathology 34:309–314
    Article PubMed Google Scholar
  17. Klein B, Weirich G, Brauch H (2001) DHPLC-based germline mutation screening in the analysis of the VHL tumor suppressor gene: usefulness and limitations. Hum Genet 108:376–384
    Article PubMed CAS Google Scholar
  18. Xiao W, Oefner PJ (2001) Denaturing high-performance liquid chromatography: a review. Hum Mutat 17:439–474
    Article PubMed CAS Google Scholar
  19. Song CG, Hu Z, Wu J et al (2006) The prevalence of BRCA1 and BRCA2 mutations in eastern Chinese women with breast cancer. J Cancer Res Clin Oncol 32:617–626
    Article CAS Google Scholar
  20. Hu Z, Wu J, Liu CH et al (2003) The analysis of BRCA1 mutations in eastern Chinese patients with early onset breast cancer and affected relatives. Hum Mutat 22:104
    Article PubMed CAS Google Scholar
  21. NCBI [http://www.ncbi.nlm.nih.gov/]

Download references

Acknowledgments

The authors thank the family members for their willingness to cooperate with our study. This research was supported in part by the grants from the National Basic Research Program of China (2006CB910501), National Natural Science Foundation of China (30371580, 30572109); Shanghai Science and Technology Committee (03J14019, 06DJ14004, 06DZ19504)

Author information

Authors and Affiliations

  1. Breast Cancer Institute, Cancer Hospital/Cancer Institute, Department of Oncology, Shanghai Medical College, Fudan University, 270 Dong’an Road, Shanghai, 200032, People’s Republic of China
    A-Yong Cao, Zhen Hu, Wen-Feng Li, Gen-Hong Di, Kun-Wei Shen, Jiong Wu, Jin-Song Lu, Jian-Min Luo, Zhen-Zhou Shen & Zhi-Ming Shao
  2. Department of Breast, Xiangya Hospital, Central South University, Changsha, People’s Republic of China
    Juan Huang & Li-Li Tang
  3. Department of Surgery, The Affiliated Hospital of Qingdao University Medical College, Qingdao, People’s Republic of China
    Zhong-Liang Ma
  4. Department of Breast Disease, Liaoning Cancer Hospital & Institute, Shenyang, People’s Republic of China
    Bin Zhang
  5. Department of Breast Surgery, Second Affiliated Hospital of Zhongshan University, Guangzhou, People’s Republic of China
    Feng-Xi Su & Jie Zhou
  6. Chinese National Human Genome Center at Shanghai, Shanghai, People’s Republic of China
    Wen-Tao Yuan & Wei Huang

Authors

  1. A-Yong Cao
    You can also search for this author inPubMed Google Scholar
  2. Juan Huang
    You can also search for this author inPubMed Google Scholar
  3. Zhen Hu
    You can also search for this author inPubMed Google Scholar
  4. Wen-Feng Li
    You can also search for this author inPubMed Google Scholar
  5. Zhong-Liang Ma
    You can also search for this author inPubMed Google Scholar
  6. Li-Li Tang
    You can also search for this author inPubMed Google Scholar
  7. Bin Zhang
    You can also search for this author inPubMed Google Scholar
  8. Feng-Xi Su
    You can also search for this author inPubMed Google Scholar
  9. Jie Zhou
    You can also search for this author inPubMed Google Scholar
  10. Gen-Hong Di
    You can also search for this author inPubMed Google Scholar
  11. Kun-Wei Shen
    You can also search for this author inPubMed Google Scholar
  12. Jiong Wu
    You can also search for this author inPubMed Google Scholar
  13. Jin-Song Lu
    You can also search for this author inPubMed Google Scholar
  14. Jian-Min Luo
    You can also search for this author inPubMed Google Scholar
  15. Wen-Tao Yuan
    You can also search for this author inPubMed Google Scholar
  16. Zhen-Zhou Shen
    You can also search for this author inPubMed Google Scholar
  17. Wei Huang
    You can also search for this author inPubMed Google Scholar
  18. Zhi-Ming Shao
    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence toZhi-Ming Shao.

Additional information

A-Yong Cao, Juan Huang, and Zhen Hu contributed equally to this work.

Rights and permissions

About this article

Cite this article

Cao, AY., Huang, J., Hu, Z. et al. The prevalence of PALB2 germline mutations in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives.Breast Cancer Res Treat 114, 457–462 (2009). https://doi.org/10.1007/s10549-008-0036-z

Download citation

Keywords